Veracyte (VCYT) News Today $30.35 +0.64 (+2.15%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$30.22 -0.14 (-0.44%) As of 05/2/2025 06:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Veracyte (VCYT) Projected to Post Quarterly Earnings on WednesdayVeracyte (NASDAQ:VCYT) will be releasing its Q1 2025 earnings after the market closes on Wednesday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-7-veracyte-inc-stock/)May 2 at 5:35 AM | marketbeat.comFirst Trust Advisors LP Acquires 124,275 Shares of Veracyte, Inc. (NASDAQ:VCYT)First Trust Advisors LP boosted its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 155.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 204,042 shares of the biotechnology company's stockMay 2 at 4:05 AM | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Shares Bought by PDT Partners LLCPDT Partners LLC raised its stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 38.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 96,632 shares of the biotechnology company's stock after purchasinMay 1 at 8:20 AM | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Shares Purchased by Lord Abbett & CO. LLCLord Abbett & CO. LLC increased its position in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 39.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 389,606 shares of the biotechnology company's stock after acquiring anApril 29, 2025 | marketbeat.comDimensional Fund Advisors LP Sells 151,056 Shares of Veracyte, Inc. (NASDAQ:VCYT)Dimensional Fund Advisors LP decreased its position in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 5.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,882,734 shares of the biotechnoApril 29, 2025 | marketbeat.comBarclays PLC Boosts Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT)Barclays PLC lifted its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 6.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 155,338 shares of the biotechnology company's stock after acquiring an additionApril 28, 2025 | marketbeat.comWells Fargo & Company MN Acquires 11,387 Shares of Veracyte, Inc. (NASDAQ:VCYT)Wells Fargo & Company MN grew its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 28.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 51,131 shares of the biotechnology company's stock after purchasiApril 28, 2025 | marketbeat.comVeracyte expands Decipher Prostate test availabilityApril 26, 2025 | markets.businessinsider.comOberweis Asset Management Inc. Raises Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT)Oberweis Asset Management Inc. increased its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 4.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 748,720 shares of the biotechnology company's stock after pApril 26, 2025 | marketbeat.comLeerink Partnrs Has Pessimistic View of Veracyte Q1 EarningsVeracyte, Inc. (NASDAQ:VCYT - Free Report) - Equities researchers at Leerink Partnrs decreased their Q1 2025 EPS estimates for Veracyte in a research report issued to clients and investors on Monday, April 21st. Leerink Partnrs analyst P. Souda now anticipates that the biotechnology company willApril 26, 2025 | marketbeat.comDark Forest Capital Management LP Buys New Position in Veracyte, Inc. (NASDAQ:VCYT)Dark Forest Capital Management LP purchased a new stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 21,337 shares of the biotechnology company's sApril 26, 2025 | marketbeat.comGuggenheim Capital LLC Purchases New Stake in Veracyte, Inc. (NASDAQ:VCYT)Guggenheim Capital LLC acquired a new position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 19,759 shares of the biotechnology company's stock, valued at approximatelyApril 26, 2025 | marketbeat.comVeracyte Inc (VCYT) Launches Decipher Prostate Metastatic Genomic Classifier | VCYT stock newsApril 25, 2025 | gurufocus.comVeracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate CancerApril 25, 2025 | businesswire.comQ2 Earnings Forecast for Veracyte Issued By Leerink PartnrsVeracyte, Inc. (NASDAQ:VCYT - Free Report) - Stock analysts at Leerink Partnrs lowered their Q2 2025 earnings estimates for Veracyte in a report issued on Monday, April 21st. Leerink Partnrs analyst P. Souda now anticipates that the biotechnology company will earn $0.24 per share for the quarter,April 25, 2025 | marketbeat.comSilverarc Capital Management LLC Boosts Holdings in Veracyte, Inc. (NASDAQ:VCYT)Silverarc Capital Management LLC lifted its stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 7.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 503,281 shares of the biotechnology company's stock after acquiriApril 24, 2025 | marketbeat.comLeerink Partnrs Increases Earnings Estimates for VeracyteVeracyte, Inc. (NASDAQ:VCYT - Free Report) - Research analysts at Leerink Partnrs lifted their FY2026 earnings per share (EPS) estimates for Veracyte in a report issued on Monday, April 21st. Leerink Partnrs analyst P. Souda now anticipates that the biotechnology company will post earnings per shApril 24, 2025 | marketbeat.comFY2026 EPS Estimates for Veracyte Boosted by Leerink PartnrsApril 24, 2025 | americanbankingnews.comLeerink Partnrs Has Negative Outlook of Veracyte Q2 EarningsApril 24, 2025 | americanbankingnews.comVeracyte Announces Multiple Abstracts Demonstrating Power of Decipher Testing To Fuel New Prostate and Bladder Cancer Insights Will Be Presented at AUA Annual MeetingApril 22, 2025 | businesswire.comShort Interest in Veracyte, Inc. (NASDAQ:VCYT) Increases By 26.4%Veracyte, Inc. (NASDAQ:VCYT - Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 4,170,000 shares, an increase of 26.4% from the March 15th total of 3,300,000 shares. Based on an average trading volume of 972,000 shares, the days-to-cover ratio is currently 4.3 days. Currently, 5.5% of the shares of the stock are sold short.April 22, 2025 | marketbeat.comVeracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute's SEER Specialized Database ReleaseApril 21, 2025 | businesswire.comZacks Investment Management Acquires 16,603 Shares of Veracyte, Inc. (NASDAQ:VCYT)Zacks Investment Management boosted its holdings in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 50.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 49,598 shares of the biotechnologApril 21, 2025 | marketbeat.comMarshall Wace LLP Increases Stock Position in Veracyte, Inc. (NASDAQ:VCYT)Marshall Wace LLP raised its position in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 768.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 956,577 shares of the biotechnology company's stock after buying an additional 846,487 shApril 21, 2025 | marketbeat.comChamplain Investment Partners LLC Cuts Stake in Veracyte, Inc. (NASDAQ:VCYT)Champlain Investment Partners LLC lessened its holdings in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 68.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 800,355 shares of the biotechnology company'April 20, 2025 | marketbeat.comRussell Investments Group Ltd. Acquires 45,876 Shares of Veracyte, Inc. (NASDAQ:VCYT)Russell Investments Group Ltd. grew its holdings in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 233.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 65,541 shares of the biotechnology company's stock afApril 20, 2025 | marketbeat.comXTX Topco Ltd Lowers Holdings in Veracyte, Inc. (NASDAQ:VCYT)XTX Topco Ltd lowered its holdings in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 56.0% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 21,223 shares of the biotechnology company's stock after selling 26,970 shares during the period.April 19, 2025 | marketbeat.comBessemer Group Inc. Sells 25,400 Shares of Veracyte, Inc. (NASDAQ:VCYT)Bessemer Group Inc. lessened its holdings in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 66.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,625 shares of the biotechnology company's stock after selling 25,400 shares during the period. BessemApril 18, 2025 | marketbeat.comLegal & General Group Plc Lowers Position in Veracyte, Inc. (NASDAQ:VCYT)Legal & General Group Plc trimmed its position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 18.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 375,499 shares of the biotechnology company's stock afterApril 18, 2025 | marketbeat.comGranite Investment Partners LLC Sells 74,537 Shares of Veracyte, Inc. (NASDAQ:VCYT)Granite Investment Partners LLC decreased its holdings in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 10.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 649,017 shares of the biotechnology company's stockApril 15, 2025 | marketbeat.comCraig-Hallum Reaffirms Their Buy Rating on Veracyte (VCYT)April 14, 2025 | markets.businessinsider.comFederated Hermes Inc. Boosts Stake in Veracyte, Inc. (NASDAQ:VCYT)Federated Hermes Inc. lifted its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 13,322.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 122,013 shares of the biotechnology company's stock afApril 14, 2025 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Shares Purchased by JPMorgan Chase & Co.JPMorgan Chase & Co. raised its stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 25.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 434,971 shares of the biotechnology company's stock afApril 14, 2025 | marketbeat.comFranklin Resources Inc. Sells 24,910 Shares of Veracyte, Inc. (NASDAQ:VCYT)Franklin Resources Inc. lessened its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 11.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 184,060 shares of the biotechnolApril 12, 2025 | marketbeat.comVeracyte (NASDAQ:VCYT) Shares Gap Down After Analyst DowngradeVeracyte (NASDAQ:VCYT) Shares Gap Down on Analyst DowngradeApril 11, 2025 | marketbeat.comGuggenheim Has Lowered Expectations for Veracyte (NASDAQ:VCYT) Stock PriceGuggenheim reduced their target price on shares of Veracyte from $45.00 to $37.00 and set a "buy" rating for the company in a report on Wednesday.April 11, 2025 | marketbeat.comDynamic Technology Lab Private Ltd Takes $424,000 Position in Veracyte, Inc. (NASDAQ:VCYT)Dynamic Technology Lab Private Ltd acquired a new position in Veracyte, Inc. (NASDAQ:VCYT - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The fund acquired 10,700 shares of the biotechnology company's stock, valued at approximately $424,000. A number of otheApril 11, 2025 | marketbeat.comNorges Bank Takes $8.93 Million Position in Veracyte, Inc. (NASDAQ:VCYT)Norges Bank purchased a new position in Veracyte, Inc. (NASDAQ:VCYT - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 225,602 shares of the biotechnology company's stock, valued at approximately $8,934,000. Norges BanApril 10, 2025 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Receives Average Rating of "Moderate Buy" from AnalystsVeracyte, Inc. (NASDAQ:VCYT - Get Free Report) has received an average rating of "Moderate Buy" from the ten research firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and eight have asApril 10, 2025 | marketbeat.comExodusPoint Capital Management LP Sells 619,608 Shares of Veracyte, Inc. (NASDAQ:VCYT)ExodusPoint Capital Management LP lessened its holdings in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 84.4% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 114,840 shares of the biotechnology company's sApril 8, 2025 | marketbeat.comCommonwealth Equity Services LLC Makes New $433,000 Investment in Veracyte, Inc. (NASDAQ:VCYT)Commonwealth Equity Services LLC acquired a new stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 10,925 shares of theApril 7, 2025 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Shares Sold by Cinctive Capital Management LPCinctive Capital Management LP trimmed its holdings in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 71.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 30,893 shares of the biotechnology company's stock after selling 78,122 sharesApril 6, 2025 | marketbeat.comBryce Point Capital LLC Buys Shares of 25,775 Veracyte, Inc. (NASDAQ:VCYT)Bryce Point Capital LLC purchased a new position in Veracyte, Inc. (NASDAQ:VCYT - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 25,775 shares of the biotechnology company's sApril 5, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Has $25.15 Million Stock Holdings in Veracyte, Inc. (NASDAQ:VCYT)Arrowstreet Capital Limited Partnership increased its position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 134.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 635,110 shares of the biotApril 5, 2025 | marketbeat.comVanguard Group Inc. Boosts Stake in Veracyte, Inc. (NASDAQ:VCYT)Vanguard Group Inc. grew its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 6.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,211,612 shares of the biotechnology company's stock after buying an additional 463,09April 5, 2025 | marketbeat.comVeracyte Inc.April 4, 2025 | wsj.comWellington Management Group LLP Decreases Holdings in Veracyte, Inc. (NASDAQ:VCYT)Wellington Management Group LLP lowered its stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 3.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,084,559 shares of the biotechnologApril 4, 2025 | marketbeat.comKLP Kapitalforvaltning AS Makes New Investment in Veracyte, Inc. (NASDAQ:VCYT)KLP Kapitalforvaltning AS acquired a new stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 15,400 shares of the biotechnology company's stock, vaApril 4, 2025 | marketbeat.comRaymond James Financial Inc. Makes New $1.63 Million Investment in Veracyte, Inc. (NASDAQ:VCYT)Raymond James Financial Inc. acquired a new stake in Veracyte, Inc. (NASDAQ:VCYT - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 41,064 shares of the biotechnology company's stock, valued at approximatelyApril 3, 2025 | marketbeat.comVeracyte, Inc. (NASDAQ:VCYT) Shares Bought by Prudential Financial Inc.Prudential Financial Inc. grew its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 602.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 122,003 shares of the biotechnology company's stock after purchasing an additional 104,6April 2, 2025 | marketbeat.com Get Veracyte News Delivered to You Automatically Sign up to receive the latest news and ratings for VCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address VCYT Media Mentions By Week VCYT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VCYT News Sentiment▼1.070.58▲Average Medical News Sentiment VCYT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VCYT Articles This Week▼77▲VCYT Articles Average Week Get Veracyte News Delivered to You Automatically Sign up to receive the latest news and ratings for VCYT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Hims & Hers Health News Today Guardant Health News Today Option Care Health News Today RadNet News Today Sotera Health News Today GeneDx News Today BrightSpring Health Services News Today Privia Health Group News Today Concentra Group Holdings Parent News Today Surgery Partners News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VCYT) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veracyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veracyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VCYT Stock Free VCYT Stock Alerts